Stedim Unifies Businesses Under Stedim Biosystems Name
News Jun 06, 2006
The Stedim Group has announced the unification of all business activities under the marketing name Stedim Biosystems.
This move will bring under one banner the original core business of single-use biotech and I.V. bags with the businesses of Integrated Biosystems (IBI) and Isolateur Dénominateur Commun (IDC) acquired in 2004.
The company logo has also been modified to reflect this change. The name change is designed to facilitate synergy between the businesses.
Further, the Stedim Biosystems name signifies that the group has grown and evolved through the successes of the core businesses and acquisitions.
This change also confirms that the activities of Stedim Biosystems are aligned to meet the challenges of the common mission.
The various activities of Stedim Biosystems will be differentiated in business and marketing communications by the use of identifying phrases: Single-use Systems, Controlled Freeze-Thaw, and Sterile Transfer.
Liliane de Lassus, CEO of Stedim Biosystems, commented, "We are very enthusiastic about uniting all Stedim business activities under the name and logo of Stedim Biosystems."
"This identity is designed to honor the successful history and extensive market recognition of the original Stedim name while pointing to the future of our specific mission in producing complete systems for bioprocessing and drug delivery."
"Only the marketing name, the name by which the company presents the businesses to clients, has been changed."
"The legal names of each business entity, which are only required in legal transactions, will remain unchanged for the foreseeable future."
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Drug Combo Prevents Stroke, Shows Promise for ClinicNews
Taking the clot-preventing drug clopidogrel along with aspirin may lower your risk of having a major stroke within the next 90 days following a TIAREAD MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018